Tobramycin - PDFSEARCH.IO - Document Search Engine

Tobramycin
Results: 62

#	Item
21	Rationale for the EUCAST clinical breakpoints Add to Reading List Source URL: www.eucast.org Language: English - Date: 2009-12-12 17:14:34 Biology Gram-positive bacteria Staphylococcaceae Antibiotics Aminoglycoside Netilmicin Amikacin Tobramycin Staphylococcus aureus Bacteria Aminoglycoside antibiotics Microbiology
22	New Drugs 4 Bad Bugs (ND4BB) Cross-project communication & collaboration COMBACTE (Topic 1) - Enabling Add to Reading List Source URL: www.imi.europa.eu Language: English - Date: 2014-03-05 10:28:43 Bronchiectasis Cystic fibrosis Antibacterial Fosfomycin/tobramycin Health Antibiotics Medicine
23	Beneficiary’s Medicaid ID# Add to Reading List Source URL: ahca.myflorida.com Language: English - Date: 2014-07-24 07:34:00 Cystic fibrosis Pediatrics Tobramycin Pseudomonas aeruginosa Medical prescription Health Medicine Channelopathy
24	Beneficiary’s Medicaid ID# Add to Reading List Source URL: www.fdhc.state.fl.us Language: English - Date: 2014-07-24 07:34:00 Cystic fibrosis Pediatrics Tobramycin Pseudomonas aeruginosa Medical prescription Health Medicine Channelopathy
25	Beneficiary’s Medicaid ID# Add to Reading List Source URL: www.fdhc.state.fl.us Language: English - Date: 2014-07-24 10:34:39 Channelopathy Cystic fibrosis Pediatrics Tobramycin Pseudomonas aeruginosa Medical prescription Health Medicine Aminoglycoside antibiotics
26	Below is a list of the JCIH Risk Indicators for Permanent Early Onset and/or Late Progressive Hearing Loss in Childhood:  Parent or caregiver concern* regarding hearing, speech, language or developmental delay. Add to Reading List Source URL: dhhs.ne.gov Language: English - Date: 2014-10-09 00:41:04 Sensorineural hearing loss Conductive hearing loss Hearing impairment Ototoxicity Infection Meningitis Tobramycin Hearing loss with craniofacial syndromes Congenital hearing loss Deafness Health Medicine
27	Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Anti-Infective Drugs Advisory Committee Meeting September 5, 2012 Location: The FDA White Oak Campus, Building 31, The Great Roo Add to Reading List Source URL: www.fda.gov Language: English Gram-negative bacteria Pseudomonadales Aminoglycoside antibiotics Food and Drug Administration Tobramycin Cystic fibrosis Pseudomonas aeruginosa Center for Drug Evaluation and Research Novartis Health Microbiology Medicine
28	NDA[removed]S-015 Page 3 Zylet™ loteprednol etabonate and tobramycin ophthalmic suspension, 0.5%/0.3% Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-06-07 09:50:05 Blindness Glucocorticoids Otologicals Keratitis Uveitis Prednisolone Tobramycin Corneal ulcer Intraocular pressure Health Ophthalmology Medicine
29	rccm2010091478ci[removed] Add to Reading List Source URL: cfcenter.stanford.edu Language: English - Date: 2011-06-06 12:40:44 Channelopathy Cystic fibrosis Pediatrics Pseudomonas infection Pseudomonas aeruginosa Bronchiectasis Cystic Fibrosis Foundation Tobramycin Chest wall oscillation Medicine Health Bacterial diseases
30	Beneficiary’s Medicaid ID# Add to Reading List Source URL: www.ahca.myflorida.com Language: English - Date: 2014-07-24 10:34:39 Channelopathy Cystic fibrosis Pediatrics Tobramycin Pseudomonas aeruginosa Medical prescription Health Medicine Aminoglycoside antibiotics

UPDATE